Trial NCT03094611

View at ClinicalTrials.gov 
Org. Study IDs: 2015-0870
Secondary IDs: 2015-0870 NCI-2018-01237 P30CA016672

Last trial update was posted on 2021-04-12

MeSH Interventions

Inotuzumab Ozogamicin

MeSH Conditions

Leukemia Leukemia, Lymphoid Precursor Cell Lymphoblastic Leukemia-Lymphoma

Other Conditions

CD22 Positive Recurrent Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia

Stopping Reasons

the study was closed early due to competing trials

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID